The article reviews a treatment program – the Karolinska project for Early treatment of Women with Alcohol Addiction (EWA) – located at the Magnus Huss Clinic, Karolinska Hospital, Stockholm, Sweden. EWA was developed by Dahlgren and collaborators to attract women early in their drinking careers by challenging women’s difficulties when seeking treatment for problem drinking. Basic structure of the EWA program is a short inpatient stay – if necessary – followed by long-term, frequent appointments at the outpatient department. Therapist stability through inpatient and outpatient services is aimed at, since stability and duration of relationship between patient and therapist seem to be important factors related to outcome. Treatment is focused on the alcohol problem, but addresses psychiatric disorders complicating the drinking problem, as well as the woman’s relationships with partner and children. The authors advocate special programs to be developed for women problem drinkers – sensitive to these women’s treatment needs and life situation. These specialized programs should also function as competence centres for health personnel dealing with female problem drinkers in a variety of treatment settings, aiming at increasing general awareness and promoting early detecion and intervention among problem drinking women.

Keywords:
Alcohol, Clinical treatment program, Problem drinking, women
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.